AUCKLAND, New Zealand – 30 January 2023: Dexcom Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, and its New Zealand subsidiary New Zealand Medical and Scientific Ltd (NZMS Diabetes) have released a School Guide to give schools the information they need to better support students with Type 1 diabetes.
The Guide aims to help schools better understand diabetes management and support students who use Continuous Glucose Monitoring (CGM) technology. CGM is a wearable technology that can help to improve the quality of life of people with Type 1 diabetes by measuring glucose levels in real time, and providing alerts when levels are outside optimal range. This means that CGM wearers no longer need to conduct the fingerprick* test multiple times a day because the technology automatically monitors glucose levels continuously, giving much greater peace of mind.
The Guide is timely considering the growing calls for subsidised access to CGM technology in New Zealand.
Kirstin Brown, Country Manager NZMS Diabetes said, “The School Guide provides important information for teachers and school administrators about the difference between CGM technology and blood glucose meters, as well as how CGM devices work and what the alerts mean on these devices.
“The Guide aims to help schools better understand and respond to CGM device alerts, and support their students in accordance with their individual diabetes management plan.
“Having a better understanding of diabetes, diabetes technologies and treatment methods in schools is important to best support students living with diabetes.”
The Dexcom School Guide can be downloaded here.
DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader in diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world. For more information about Dexcom CGM, visit https://www.dexcom.com/en-NZ
About NZMS Diabetes
NZMS and its Australian branch, AMSL, are subsidiaries of Dexcom. NZMS Diabetes is the New Zealand distributor of the Dexcom G6 and the new Dexcom G7 CGM systems, t:slim X2 insulin pumps, and other diabetes devices and accessories. For more information on NZMS Diabetes, please visit nzmsdiabetes.co.nz
*If your glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions
Dexcom releases a School Guide to help schools with their understanding and response to diabetes management.
Now you can get all the latest news and updates of our products, events and resources right into your inbox.
We are always happy to help, send us a message or enquiry